1-4 of 4
Hongjiao Ouyang
Close
Sort by
Journal Articles

Expression of XBP1s in bone marrow stromal cells is critical for myeloma cell growth and osteoclast formation

Guoshuang Xu, Kai Liu, Judy Anderson, Kenneth Patrene, Suzanne Lentzsch, G. David Roodman, Hongjiao Ouyang
Journal: Blood
Blood (2012) 119 (18): 4205–4214.
https://doi.org/10.1182/blood-2011-05-353300
Published: 2012
Includes: Supplemental data
Journal Articles

IMiD immunomodulatory compounds block C/EBPβ translation through eIF4E down-regulation resulting in inhibition of MM

Shirong Li, Rekha Pal, Sara A. Monaghan, Peter Schafer, Hongjiao Ouyang, Markus Mapara, Deborah L. Galson, Suzanne Lentzsch
Journal: Blood
Blood (2011) 117 (19): 5157–5165.
https://doi.org/10.1182/blood-2010-10-314278
Published: 2011
Includes: Supplemental data
Journal Articles

C/EBPb Is a Critical Mediator of Resistance to IMiD® Immunomodulatory Compounds and Affected by IMiD Compounds Via Control of Protein Translation

Shirong Li, PhD, Rekha Pal, PhD, Sara Monaghan, MD, Peter Schafer, PhD, Hongjiao Ouyang, DDS, PhD, Markus Y Mapara, MD, PhD, Suzanne Lentzsch, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 135.
https://doi.org/10.1182/blood.V116.21.135.135
Published: 2010
Journal Articles

Lenalidomide Shuts Down the Translational Machinery in Multiple Myeloma Cells Resulting in Down-Regulation of Critical Transcription Factors Such as C/EBPβ and IRF4.

Shirong Li, PhD, Rekha Pal, PhD, Deborah L Galson, Ph.D., Peter H Schafer, PhD, Hongjiao Ouyang, DDS, PhD, Markus Y Mapara, MD, PhD, Suzanne Lentzsch, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 1844.
https://doi.org/10.1182/blood.V114.22.1844.1844
Published: 2009